349 related articles for article (PubMed ID: 9017166)
1. Treatment of drug-induced agranulocytosis with colony stimulating factors (G-CSF or GM-CSF).
Góra-Tybor J; Krykowski E; Robak T
Arch Immunol Ther Exp (Warsz); 1996; 44(4):255-8. PubMed ID: 9017166
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of methimazole-induced agranulocytosis with granulocyte-macrophage colony stimulating factor].
Somogyi A; Werling K; Rosta A; Láng I
Orv Hetil; 1994 Nov; 135(45):2483-5. PubMed ID: 7991239
[TBL] [Abstract][Full Text] [Related]
3. The role of haematopoietic growth factors granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the management of drug-induced agranulocytosis.
Andrès E; Maloisel F; Zimmer J
Br J Haematol; 2010 Jul; 150(1):3-8. PubMed ID: 20151980
[TBL] [Abstract][Full Text] [Related]
4. Drug-induced agranulocytosis treated with granulocyte-macrophage colony stimulating factor.
Hurtado R; Candelaria M; Majluf-Cruz A; Sosa-Camas RE; Labardini-Méndez J
Rev Invest Clin; 1994; 46(1):59-61. PubMed ID: 8079066
[TBL] [Abstract][Full Text] [Related]
5. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
Wong SF; Chan HO
Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
[TBL] [Abstract][Full Text] [Related]
6. G-CSF and the management of clozapine-induced agranulocytosis.
Gerson SL
J Clin Psychiatry; 1994 Sep; 55 Suppl B():139-42. PubMed ID: 7525542
[TBL] [Abstract][Full Text] [Related]
7. [Hematopoietic growth factors as supportive treatment in drug-induced agranulocytosis].
Hospers GA; de Wolf JT; Hazenberg BP; Vellenga E
Ned Tijdschr Geneeskd; 1993 Oct; 137(42):2152-4. PubMed ID: 7694163
[TBL] [Abstract][Full Text] [Related]
8. Granulocyte-macrophage colony-stimulating factor (GM-CSF) treatment of clozapine-induced agranulocytosis: a case report.
Barnas C; Zwierzina H; Hummer M; Sperner-Unterweger B; Stern A; Fleischhacker WW
J Clin Psychiatry; 1992 Jul; 53(7):245-7. PubMed ID: 1639744
[TBL] [Abstract][Full Text] [Related]
9. Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients.
Palmeri S; Leonardi V; Danova M; Porta C; Ferrari S; Fincato G; Citarrella P
Haematologica; 1999 Nov; 84(11):1016-23. PubMed ID: 10553163
[TBL] [Abstract][Full Text] [Related]
10. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
Bruserud O; Foss B; Petersen H
Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
[TBL] [Abstract][Full Text] [Related]
11. The application of hematopoietic growth factors in drug-induced agranulocytosis: a review of 70 cases.
Sprikkelman A; de Wolf JT; Vellenga E
Leukemia; 1994 Dec; 8(12):2031-6. PubMed ID: 7528854
[TBL] [Abstract][Full Text] [Related]
12. Use of granulocyte colony-stimulating factor (G-CSF) and outcome in patients with non-chemotherapy agranulocytosis.
Ibáñez L; Sabaté M; Ballarín E; Puig R; Vidal X; Laporte JR;
Pharmacoepidemiol Drug Saf; 2008 Mar; 17(3):224-8. PubMed ID: 18181220
[TBL] [Abstract][Full Text] [Related]
13. Sulfasalazine induced agranulocytosis treated with granulocyte-macrophage colony stimulating factor.
Kuipers EJ; Vellenga E; de Wolf JT; Hazenberg BP
J Rheumatol; 1992 Apr; 19(4):621-2. PubMed ID: 1350640
[TBL] [Abstract][Full Text] [Related]
14. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
[TBL] [Abstract][Full Text] [Related]
15. [Low-dose granulocyte colony-stimulating factor combined with granulocyte-macrophage colony-stimulating factor for mobilizing peripheral CD34+ hematopoietic progenitor cells].
Meng FY; Xu B; Sun J; Yang Y; Niu JN
Di Yi Jun Yi Da Xue Xue Bao; 2004 Sep; 24(9):1051-2. PubMed ID: 15447861
[TBL] [Abstract][Full Text] [Related]
16. Treatment of methimazole-induced agranulocytosis using recombinant human granulocyte colony-stimulating factor (rhG-CSF).
Tamai H; Mukuta T; Matsubayashi S; Fukata S; Komaki G; Kuma K; Kumagai LF; Nagataki S
J Clin Endocrinol Metab; 1993 Nov; 77(5):1356-60. PubMed ID: 7521347
[TBL] [Abstract][Full Text] [Related]
17. The treatment of clozapine-associated agranulocytosis with granulocyte colony-stimulating factor (G-CSF).
Chengappa KN; Gopalani A; Haught MK; McChesney K; Baker RW; Schooler NR
Psychopharmacol Bull; 1996; 32(1):111-21. PubMed ID: 8927660
[TBL] [Abstract][Full Text] [Related]
18. Treatment of clozapine-induced agranulocytosis with recombinant granulocyte colony-stimulating factor.
Gullion G; Yeh HS
J Clin Psychiatry; 1994 Sep; 55(9):401-5. PubMed ID: 7523362
[TBL] [Abstract][Full Text] [Related]
19. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: comparisons and potential for use in the treatment of infections in nonneutropenic patients.
Root RK; Dale DC
J Infect Dis; 1999 Mar; 179 Suppl 2():S342-52. PubMed ID: 10081506
[TBL] [Abstract][Full Text] [Related]
20. Treatment of drug-induced bone marrow suppression with recombinant human granulocyte/monocyte colony stimulating factor.
Somogyi A; Rosta A; Lang I; Werling K
Adverse Drug React Toxicol Rev; 1996 Jun; 15(2):119-24. PubMed ID: 8836317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
